- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: GP MDI 28.8 μg
Total 34 results
-
Pearl Therapeutics, Inc.Completed
-
Pearl Therapeutics, Inc.CompletedCOPD, Chronic Obstructive Pulmonary DiseaseBelgium
-
AstraZenecaRecruitingAsthmaUnited States, China, Czechia, Germany, South Africa, United Kingdom, Mexico, Turkey, Colombia, Russian Federation, Brazil, Israel, Greece, Portugal, Austria, Costa Rica, Saudi Arabia, Slovakia, Sweden, Puerto Rico
-
AstraZenecaRecruitingAsthmaUnited States, Canada, Denmark, Hungary, New Zealand, Poland, Spain, Korea, Republic of, Philippines, Italy, Argentina, Bulgaria, India, Japan, Vietnam, Taiwan, Thailand, Peru, Chile, Puerto Rico, Belgium, Australia, Netherlands, Romania
-
Pearl Therapeutics, Inc.CompletedChronic Obstructive Pulmonary DiseaseUnited States
-
Pearl Therapeutics, Inc.CompletedCOPDUnited States, Austria, Canada, France, Germany, Italy, Netherlands, Spain, Sweden, United Kingdom, Peru, Russian Federation, Hungary, China, Taiwan, Australia, Japan, Argentina, South Africa, Belgium, Czechia, Serbia, Poland, Mexico, New... and more
-
Pearl Therapeutics, Inc.Completed
-
AstraZenecaRecruitingCOPD (Chronic Obstructive Pulmonary Disease)France, Denmark, Italy, Spain, United States, Canada, Argentina, Japan, Colombia, Germany, Peru, Brazil, China, India, Thailand, Austria, Serbia, Malaysia, Philippines, Poland, Taiwan, Greece, Norway, Sweden, Mexico, Romania, Korea, Republic... and more
-
AstraZenecaRecruitingAsthmaUnited States, Canada, South Africa, Korea, Republic of, Philippines, Czechia, Malaysia, Germany
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)United States, Canada, Germany, Argentina, Bulgaria, Poland, Turkey, Mexico, United Kingdom
-
AstraZenecaRecruitingAsthmaUnited States, Canada, Italy, Japan, Vietnam, Spain, Germany, Malaysia
-
Pearl Therapeutics, Inc.Completed
-
Pearl Therapeutics, Inc.CompletedChronic Obstructive Pulmonary DiseaseJapan
-
AstraZenecaCompleted
-
Pearl Therapeutics, Inc.CompletedChronic Obstructive Pulmonary DiseaseUnited States, Germany, United Kingdom, China, Taiwan, Korea, Republic of, Japan, Czechia, Hungary, Poland, Russian Federation
-
Pearl Therapeutics, Inc.CompletedChronic Obstructive Pulmonary DisorderUnited States, Canada, Germany, Hungary, Korea, Republic of, Poland, Russian Federation, Czechia
-
Pearl Therapeutics, Inc.CompletedChronic Obstructive Pulmonary DisorderUnited States, Austria, Belgium, Canada, Denmark, Germany, Italy, Spain, Sweden, United Kingdom, Peru, Brazil, South Africa, Argentina, Russian Federation, Mexico, Puerto Rico, Chile, Norway
-
Pearl Therapeutics, Inc.CompletedChronic Obstructive Pulmonary Disease (COPD)United States
-
Bond Avillion 2 Development LPCompletedAsthmaUnited States, Germany, Ukraine, Serbia, Czechia, Argentina, Slovakia
-
Pearl Therapeutics, Inc.CompletedChronic Obstructive Pulmonary DiseaseAustralia, United States, New Zealand
-
Pearl Therapeutics, Inc.CompletedChronic Obstructive Pulmonary DiseaseUnited States, Australia, New Zealand
-
Pearl Therapeutics, Inc.CompletedChronic Obstructive Pulmonary DiseaseUnited States
-
Pearl Therapeutics, Inc.CompletedChronic Obstructive Pulmonary Disease (COPD)United States, Australia, New Zealand
-
AstraZenecaRecruiting
-
Bond Avillion 2 Development LPCompleted
-
Pearl Therapeutics, Inc.CompletedChronic Obstructive Pulmonary DiseaseUnited States, Australia, New Zealand
-
AstraZenecaRecruitingCOPD (Chronic Obstructive Pulmonary Disease)United States, Korea, Republic of, Argentina, Turkey, Vietnam, Malaysia, Philippines, Thailand, Hungary, Mexico, Canada, India, Bulgaria, Poland
-
Bond Avillion 2 Development LPCompleted
-
NovartisSchering-PloughCompleted
-
The First Affiliated Hospital with Nanjing Medical...National Natural Science Foundation of ChinaUnknownCoronary Artery DiseaseChina
-
Chiesi Farmaceutici S.p.A.Completed
-
Pearl Therapeutics, Inc.Completed
-
H. Lee Moffitt Cancer Center and Research InstituteBristol-Myers Squibb; National Cancer Institute (NCI); MedarexCompleted
-
H. Lee Moffitt Cancer Center and Research InstituteBristol-Myers Squibb; National Cancer Institute (NCI); MedarexCompletedMelanoma (Skin)United States